- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05955651
Prospective Analysis to Detect Myometrial Cells in Peritoneal Washing in Patients Undergoing Minimally Invasive Hysterectomy Using Containment Bag at University of Texas Medical Branch
August 1, 2025 updated by: The University of Texas Medical Branch, Galveston
The Aim of the study is to determine endometrial/myometrial spillage during total laparoscopic hysterectomy with manual morcellation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This will be a single institution prospective analysis study.
The study will include 50 women who are undergoing minimally invasive hysterectomy.
Surgery will be done from 08/01/2023 to 08/01/2024, for benign conditions with uterus that is > 10 cm that requires contained bag morcellation such as (Fibroids, Adenomyosis, Endometriosis, abnormal uterine bleeding, pelvic organ prolapse).
Three Samples of peritoneal washings will be collected and send to pathology.
First washing will be collected after entering the abdominal cavity, second washing will be done after completion of hysterectomy and containment of the uterus in the bag, and the third washing after scalpel morcellation of the uterus in the containment bag and extraction within the bag.
Extraction of the specimen will be done either through the vagina or through a mini laparotomy incision (2-3 cm).
Study Type
Observational
Enrollment (Actual)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Galveston, Texas, United States, 77555
- University of Texas Medical Branch
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Women needing minimally invasive hysterectomy for benign conditions, 18 years and older.
Description
Inclusion Criteria:
- Women undergoing minimally invasive Laparoscopic / Robotic hysterectomy for presumably benign conditions such as (fibroids, adenomyosis, endometriosis, pelvic organ prolapse, abnormal uterine bleeding)
- Large size uterus measuring more than 10 cm on US requiring cold knife morcellation within the Alexis containment bag, surgery will be done by designated surgeon at UTMB from 08/01/2023 to 08/01/2024.
- Women 18 years and older
- Subjects must be able to provide consents.
- Normal endometrial biopsy.
- Normal cervical cancer screening
Exclusion Criteria:
- Known Gynecological malignancy.
- Endometrial biopsy with endometrial intraepithelial hyperplasia.
- History of exposure to pelvic radiation
- Post-menopausal patients
- Emergency hysterectomy
- TDC patients
- Patient less than 18 years old
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Pelvic washings
Three Samples of peritoneal washings will be collected and send to pathology.
looking for myometrial cell spillage at three designated points in surgery.
1st before hysterectomy, 2nd after hysterectomy, and 3rd after morcellation and extraction of the uterus out of the abdominal cavity.
|
Peritoneal washing will be done at designated point in the surgical procedure. one hundred cc of normal saline, will be used to irrigate the peritoneal cavity. Samples of the fluid will be collected, with the goal to collect as much fluid as possible for the study, with minimum of 60 cc should be collected. Samples will be sent to the pathology lab.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Detection of myometrial cell spillage in peritoneal washing
Time Frame: Pelvic washing samples will be sent the pathology lab to be examined within 2 days of the surgery.
|
To evaluate potential cell spillage from morcellated tissue, the 3 peritoneal washings collected will be sent to cytology lab to be examined for the presence of smooth muscle cells
|
Pelvic washing samples will be sent the pathology lab to be examined within 2 days of the surgery.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Timing of myometrial cell spillage during hysterectomy
Time Frame: Pelvic washing samples will be sent the pathology lab to be examined within 2 days of the surgery.
|
To determine at what stage myometrial cell spillage happens during a minimally invasive hysterectomy surgery (before, after completion of the hysterectomy or after morcellation and tissue extraction)
|
Pelvic washing samples will be sent the pathology lab to be examined within 2 days of the surgery.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2023
Primary Completion (Actual)
June 10, 2025
Study Completion (Actual)
June 10, 2025
Study Registration Dates
First Submitted
July 13, 2023
First Submitted That Met QC Criteria
July 13, 2023
First Posted (Actual)
July 21, 2023
Study Record Updates
Last Update Posted (Actual)
August 5, 2025
Last Update Submitted That Met QC Criteria
August 1, 2025
Last Verified
August 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- 22-0269
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hysterectomy
-
Hitit UniversityErol Olcok Corum Training and Research HospitalCompletedHysterectomy (MeSH nr: E04.950.300.399) | Had Undergone a Hysterectomy | Had Not Been Diagnosed With Cancer | After HysterectomyTurkey (Türkiye)
-
Zuyderland Medisch CentrumCatharina Ziekenhuis EindhovenRecruitingHysterectomy | Natural Orifice Transluminal Endoscopic Surgery | Vaginal HysterectomyNetherlands
-
Muğla Sıtkı Koçman UniversityCompletedAbdominal Hysterectomy | Laparoscopic Hysterectomy
-
Università degli Studi di FerraraRecruiting
-
GCS Ramsay Santé pour l'Enseignement et la RechercheCompleted
-
University Hospitals Cleveland Medical CenterWithdrawn
-
Atlantic Health SystemUnknownHysterectomyUnited States
-
Brigham and Women's HospitalMassachusetts General HospitalCompletedHysterectomyUnited States
-
Case Comprehensive Cancer CenterWithdrawnHysterectomy
-
Cairo UniversityUnknown
Clinical Trials on Peritoneal washings
-
Memorial Sloan Kettering Cancer CenterCompletedGastric and Pancreatic CancerUnited States
-
Rigshospitalet, DenmarkDanish Cancer SocietyCompletedGastroesophageal-junction CancerDenmark
-
Karolinska InstitutetRegion Örebro CountyCompletedHernia, Ventral | Seroma as Procedural ComplicationSweden
-
Zhongshan Hospital Xiamen UniversityUnknown
-
Bezmialem Vakif UniversityCompletedGastric Cancer | Gastric AdenocarcinomaTurkey
-
Sunnybrook Health Sciences CentreNot yet recruitingPeritoneal Dialysis Complication | Peritoneal Dialysis Access FailureCanada
-
Chinese PLA General HospitalCompletedKidney Failure,ChronicChina
-
Peking University Aerospace Centre HospitalNot yet recruiting
-
Charite University, Berlin, GermanyUnknown
-
University of AlbertaWomen and Children's Health Research Institute, CanadaCompletedHypoplastic Left Heart SyndromeCanada